Oncomine analysis also revealed that CDC20 was significantly expressed higher in medullary breast carcinoma, invasive ductal breast carcinoma, invasive lobular breast carcinoma, invasive breast carcinoma, invasive ductal and invasive lobular breast carcinoma, breast carcinoma, mucinous breast carcinoma, tubular breast carcinoma, intraductal cribriform breast adenocarcinoma, invasive ductal breast carcinoma, invasive breast carcinoma, mixed lobular and ductal breast carcinoma, invasive lobular breast carcinoma, ductal breast carcinoma with respect to normal individuals (Figure 3 and Table 1). Here, CDC20 is linked to invasive ductal breast carcinoma.